Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Bruce

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
The Journal of Gene Medicine|December 31, 2008
Human beta-defensin-3 promotes wound healing in infected diabetic woundsTobias Hirsch, Malte Spielmann, Baraa Zuhaili, et al.
International Journal of Technology Assessment in Health Care|May 16, 2024
An operationalization framework for lifecycle health technology assessment: a Health Technology Assessment International Global Policy Forum Task Force reportFranz B Pichler, Meindert Boysen, Nicole Mittmann, et al.
International Journal of Technology Assessment in Health Care|May 10, 2024
Lifecycle HTA: promising applications and a framework for implementation. An HTAi Global Policy Forum Task Force reportFranz B Pichler, Meindert Boysen, Nicole Mittmann, et al.
Cell Transplantation|August 15, 2012
A population of selected renal cells augments renal function and extends survival in the ZSF1 model of progressive diabetic nephropathyRusty Kelley, Andrew Bruce, Tom Spencer, et al.
The Journal of Experimental Medicine|August 1, 2007
Human hepatic stem cells from fetal and postnatal donorsEva Schmelzer, Lili Zhang, Andrew Bruce, et al.
Methods in Cell Biology|April 30, 2008
Hepatic stem cells and hepatoblasts: identification, isolation, and ex vivo maintenanceEliane Wauthier, Eva Schmelzer, William Turner, et al.
The Lancet. HIV|November 6, 2022
Fee for home delivery and monitoring of antiretroviral therapy for HIV infection compared with standard clinic-based services in South Africa: a randomised controlled trialRuanne V Barnabas, Adam A Szpiro, Xolani Ntinga, et al.
Trials|September 14, 2022
Study protocol for a phase 1/2, single-centre, double-blind, double-dummy, randomized, active-controlled, age de-escalation trial to assess the safety, tolerability and immunogenicity of a measles and rubella vaccine delivered by a microneedle patch in healthy adults (18 to 40 years), measles and rubella vaccine-primed toddlers (15 to 18 months) and measles and rubella vaccine-naïve infants (9 to 10 months) in The Gambia [Measles and Rubella Vaccine Microneedle Patch Phase 1/2 Age De-escalation Trial]Ikechukwu Adigweme, Edem Akpalu, Mohammed Yisa, et al.
Lancet (London, England)|May 2, 2024
A measles and rubella vaccine microneedle patch in The Gambia: a phase 1/2, double-blind, double-dummy, randomised, active-controlled, age de-escalation trialIkechukwu Adigweme, Mohammed Yisa, Michael Ooko, et al.
Blood|June 30, 2026
TRANSFORM-1 Phase 3 study: Efficacy and safety of navitoclax plus ruxolitinib in patients with untreated myelofibrosisNaveen Pemmaraju, Adam J Mead, Tim C P Somervaille, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
The Journal of Gene Medicine|December 31, 2008
Human beta-defensin-3 promotes wound healing in infected diabetic woundsTobias Hirsch, Malte Spielmann, Baraa Zuhaili, et al.
International Journal of Technology Assessment in Health Care|May 16, 2024
An operationalization framework for lifecycle health technology assessment: a Health Technology Assessment International Global Policy Forum Task Force reportFranz B Pichler, Meindert Boysen, Nicole Mittmann, et al.
International Journal of Technology Assessment in Health Care|May 10, 2024
Lifecycle HTA: promising applications and a framework for implementation. An HTAi Global Policy Forum Task Force reportFranz B Pichler, Meindert Boysen, Nicole Mittmann, et al.
Cell Transplantation|August 15, 2012
A population of selected renal cells augments renal function and extends survival in the ZSF1 model of progressive diabetic nephropathyRusty Kelley, Andrew Bruce, Tom Spencer, et al.
The Journal of Experimental Medicine|August 1, 2007
Human hepatic stem cells from fetal and postnatal donorsEva Schmelzer, Lili Zhang, Andrew Bruce, et al.
Methods in Cell Biology|April 30, 2008
Hepatic stem cells and hepatoblasts: identification, isolation, and ex vivo maintenanceEliane Wauthier, Eva Schmelzer, William Turner, et al.
The Lancet. HIV|November 6, 2022
Fee for home delivery and monitoring of antiretroviral therapy for HIV infection compared with standard clinic-based services in South Africa: a randomised controlled trialRuanne V Barnabas, Adam A Szpiro, Xolani Ntinga, et al.
Trials|September 14, 2022
Study protocol for a phase 1/2, single-centre, double-blind, double-dummy, randomized, active-controlled, age de-escalation trial to assess the safety, tolerability and immunogenicity of a measles and rubella vaccine delivered by a microneedle patch in healthy adults (18 to 40 years), measles and rubella vaccine-primed toddlers (15 to 18 months) and measles and rubella vaccine-naïve infants (9 to 10 months) in The Gambia [Measles and Rubella Vaccine Microneedle Patch Phase 1/2 Age De-escalation Trial]Ikechukwu Adigweme, Edem Akpalu, Mohammed Yisa, et al.
Lancet (London, England)|May 2, 2024
A measles and rubella vaccine microneedle patch in The Gambia: a phase 1/2, double-blind, double-dummy, randomised, active-controlled, age de-escalation trialIkechukwu Adigweme, Mohammed Yisa, Michael Ooko, et al.
Blood|June 30, 2026
TRANSFORM-1 Phase 3 study: Efficacy and safety of navitoclax plus ruxolitinib in patients with untreated myelofibrosisNaveen Pemmaraju, Adam J Mead, Tim C P Somervaille, et al.
Pageof 3